腫瘍免疫薬市場 - 2031年の成長予測、統計および事実

  • Report Code : TIPRE00004055
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

市場概要 がん免疫療法とも呼ばれる腫瘍免疫学は、がんの増殖に抵抗する体の自然な防御機能を強化する生物学的治療法です。この療法は、免疫システムの機能を再確立または改善するために、身体または研究室で作られた成分を利用します。免疫腫瘍学は、身体自身の免疫系を利用してがん細胞と戦うことを目的とした最先端のがん研究技術です。現在、世界はこの分野の最前線にあり、さまざまな悪性腫瘍に使用するために多くの物質が開発中であるほか、承認された腫瘍免疫薬も新たな用途に向けて研究中です。 市場範囲 「2031年までの世界の免疫腫瘍薬市場分析」は、世界市場の傾向分析に特に焦点を当てた、ヘルスケア業界の専門的で詳細な調査です。このレポートは、薬剤の種類、治療用途、エンドユーザーごとに詳細な市場分割を行い、免疫腫瘍薬市場の概要を提供することを目的としています。このレポートは、がん免疫治療薬市場の主要企業の市場状況に関する主要な統計を提供し、市場の主要な傾向と機会を提供します。市場セグメンテーション
    • 薬剤の種類に基づいて、市場は免疫チェックポイント阻害剤、モノクローナル抗体、サイトカインベースの免疫療法、がんワクチン、Car-T 細胞療法に分類されます。 • 治療用途に基づいて、市場は黒色腫、肺がん、血液がん、腎細胞がん、前立腺がん、膀胱がんなどに分類されます。 • エンドユーザーに基づいて、市場は病院、診療所、外来手術センターに分類されます。
市場力学 要因:
    • 世界中でがんの有病率が増加していることが、市場成長の重要な原動力となっています。 • 悪性腫瘍を管理するための免疫療法薬の採用が増加しています。 • がんおよび悪性腫瘍の管理のための、より標的を絞った治療法を開発および導入するための広範な研究開発活動。
拘束:
    • ただし、治療に関連する高額なコストが予測期間中の市場の成長を抑制すると予想されます。
このレポートは、定性的情報と定量的情報の両方を含む業界の詳細な概要を提供します。さまざまなセグメントに基づいた世界市場の概要と予測を提供します。また、次の 5 つの主要地域に関して、2021 年から 2031 年までの市場規模と予測推定値も提供します。北米、ヨーロッパ、アジア太平洋 (APAC)、中東およびアフリカ (MEA)、南米。各地域ごとの腫瘍免疫薬市場は、その後、それぞれの国とセグメントごとにサブセグメント化されます。このレポートでは、世界 18 か国の分析と予測、およびこの地域に広がる現在の傾向と機会について取り上げています。レポートは、需要と供給の両方の側面から市場に影響を与える要因を分析し、予測期間中に市場に影響を与える市場のダイナミクス、つまり推進力、制約、機会、将来の傾向をさらに評価します。このレポートは、5 つの地域すべてに対する徹底的な PEST 分析も提供します。北米、ヨーロッパ、APAC、MEA、南米のこれらの地域の腫瘍免疫薬市場に影響を与える政治的、経済的、社会的、技術的要因を評価した後。腫瘍免疫薬市場に対する新型コロナウイルス感染症(COVID-19) の影響 新型コロナウイルス感染症(COVID-19)は、2021 年 12 月に初めて武漢(中国)で発生し、それ以来、速いペースで世界中に広がりました。米国、インド、ブラジル、ロシア、フランス、英国、トルコ、イタリア、スペインは、感染者数と死亡報告数で最も深刻な影響を受けている国の一部です。新型コロナウイルス感染症は、ロックダウン、渡航禁止、事業停止などにより、さまざまな国の経済や産業に影響を与えています。さまざまな工場や工場の閉鎖は世界のサプライチェーンに影響を及ぼし、世界市場での製品の製造、納期スケジュール、販売に悪影響を及ぼしています。製品納期の遅延や自社製品の将来の売上不振の可能性をすでに発表している企業はほとんどない。現在の市場状況に応じて、レポートは新型コロナウイルス感染症のパンデミックが市場全体に及ぼす現在および将来の影響をさらに評価し、より信頼性の高い本物の予測を提供しています。これに加えて、ヨーロッパ、アジア諸国が課している世界的な渡航禁止措置も影響しています。太平洋地域と北米は、ビジネスコラボレーションやパートナーシップの機会に影響を与えています。 市場関係者 このレポートでは、有機的および無機的な成長戦略としてのがん免疫療法薬市場の主要な発展について取り上げています。さまざまな企業が、製品の発売、製品の承認、特許やイベントなどの有機的な成長戦略に焦点を当てています。市場で目撃された無機質な成長戦略活動は、買収、パートナーシップ、コラボレーションでした。これらの活動により、市場プレーヤーのビジネスと顧客ベースの拡大への道が開かれました。腫瘍免疫薬市場からの支払者は、世界市場での腫瘍免疫薬の需要の高まりに伴い、将来的に有利な成長機会が期待されています。レポートには、腫瘍免疫薬市場における主要企業のSWOT分析と市場戦略とともにプロフィールも含まれています。さらに、このレポートは業界の主要企業に焦点を当てており、企業概要、提供されるコンポーネント、サービス、過去 3 年間の財務情報、過去 5 年間の主要な開発などの情報を提供します。 • アムジェン社 • アストラゼネカ • ブリストル・マイヤーズ スクイブ社 • リリー • サノフィ •  F. ホフマン=ラ ロッシュ • ノバルティス AG • アッヴィ株式会社 • ファイザー株式会社 •  The Insight Partner の専任調査分析チームである Merck KGaA は、高度な統計専門知識を持つ経験豊富な専門家で構成されており、既存の調査にさまざまなカスタマイズ オプションを提供します。
  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is the expected CAGR of the Immuno-Oncology Drugs Market?

Immuno-Oncology Drugs Market is expected to grow at a CAGR of 20.5% between 2023-2031

What are the driving factors impacting the Immuno-Oncology Drugs Market?

The driving factors impacting the Immuno-Oncology Drugs Market are: Rising Cancer Incidence and Advancements in Immunotherapy

What are the future trends of the Immuno-Oncology Drugs Market?

The future trends of the Immuno-Oncology Drugs Market are: Combination Therapies and Personalized Medicine

Which are the leading players operating in the Immuno-Oncology Drugs Market?

The leading players of the Immuno-Oncology Drugs Market are: Amgen, Inc., AstraZeneca, Bristol-Myers Squibb Company, Lilly, Sanofi, F. Hoffmann-La Roche, Novartis AG, AbbVie, Inc., Pfizer Inc., Merck KGaA

What are the deliverable formats of the Immuno-Oncology Drugs Market report?

The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.

What are the options available for the customization of this report?

Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies

- Amgen, Inc.
- AstraZeneca
- Bristol-Myers Squibb Company
- Lilly
- Sanofi
- F. Hoffmann-La Roche
- Novartis AG
- AbbVie, Inc.
- Pfizer Inc.
- Merck KGaA,
- Incyte
- GlaxoSmithKline, Inc
- Genentech, Inc
- Johnson and Johnson Services, Inc

Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.